Publications by authors named "Peter O Hofgaard"

Claim this Profile
I
Id-neoantigen vaccine induces therapeutic CD8 T cells against multiple myeloma: H chain-loss escapees cause FLC MM.
Marita Westhrin, Jana Blazevski, Ana Textor, Pegah Abdollahi, Ramakrishna Prabhu Gopalakrishnan, Peter Olaf Hofgaard

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of a Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma.
Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, Catherine Chauvet, Séverine Marionneau-Lambot, Peter O Hofgaard

Pharmaceutics· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.
Jiro Kikuchi, Daisuke Koyama, Taeko Wada, Tohru Izumi, Peter O Hofgaard

J Clin Invest· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
Ole Audun Werner Haabeth, Anders Aune Tveita, Marte Fauskanger, Fredrik Schjesvold, Kristina Berg Lorvik, Peter O Hofgaard

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease.
Peter O Hofgaard, Henriette C Jodal, Kurt Bommert, Bertrand Huard, Jo Caers

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model.
Virginie Follin-Arbelet, Peter O Hofgaard, Harald Hauglin, Soheil Naderi, Anders Sundan

BMC Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
Alexandre Corthay, Katrin U Lundin, Kristina Berg Lorvik, Peter O Hofgaard, Bjarne Bogen

Cancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary antitumor immune response mediated by CD4+ T cells.
Alexandre Corthay, Dag K Skovseth, Katrin U Lundin, Egil Røsjø, Hilde Omholt, Peter O Hofgaard

Immunity· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo.
Katrin U Lundin, Valentina Screpanti, Hilde Omholt, Peter O Hofgaard, Hideo Yagita

Cancer Immunol Immunother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies.
Katrin U Lundin, Peter O Hofgaard, Hilde Omholt, Ludvig A Munthe, Alexandre Corthay

Blood· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis